| ID | 506 |
|---|
| No | 506 |
|---|
| Brand Name | HERCEPTIN 150MG |
|---|
| Ingredients | TRASTUZUMAB 150MG |
|---|
| Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 4 YEARS |
|---|
| Pack Size | 150 MG/VIAL/BOX |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | METASTATIC BREAST CANCER AS MONOTHERAPY OR IN COMBINATION WITH PACLITAXEL OR DOCETAXEL OR AROMATASE INHIBITOR;- EARLY BREAST CANCER FOLLOWING SURGERY, CHEMOTHERAPY AND RADIOTHERAPY; ADVANCED GASTRIC CANCER IN COMBINATION WITH CAPECITABINE OR INTRAVENOUS 5 FLUOROURACIL AND PLATINUM AGENT. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | WHITE TO PALE YELLOW LYOPHILIZED CAKE GIVES CLEAR TO SLIGHTLY OPALESCENT LIQUID, COLORLESS AFTER RECONSTITUTION |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | ROCHE DIAGNOSTICS GMBH |
|---|
| Country | SWITZERLAND |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 07 I 2316/04 |
|---|
| FDD Registration Date | 25-SEP-2024 |
|---|
| Expiry Date | 24-SEP-2029 |
|---|
